Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.
Fraunhofer Cluster of Excellence for Immune-Mediated Disease, Frankfurt, Germany.
Nat Commun. 2022 Sep 5;13(1):5225. doi: 10.1038/s41467-022-32866-0.
CAR T cell therapy is an effective cancer treatment, but biological and manufacturing hurdles hamper its broad breakthrough. Although the first step towards automated manufacture of CAR cells has been taken, new technologies are needed to enable the treatment of large patient groups.
嵌合抗原受体 T 细胞疗法是一种有效的癌症治疗方法,但生物和制造方面的障碍阻碍了其广泛突破。虽然已经朝着 CAR 细胞的自动化制造迈出了第一步,但仍需要新技术来实现对大量患者群体的治疗。